Literature DB >> 2943234

Treatment of gram-negative folliculitis with isotretinoin.

U Neubert, G Plewig, A Ruhfus.   

Abstract

The clinical and bacteriological findings are reported in 13 patients with gram-negative folliculitis before, during, and after treatment with isotretinoin (13-cis-retinoic acid). Patients were treated for 14-36 weeks with a daily dose of 0.5-1.5 mg isotretinoin/kg body weight. Inflammatory lesions were counted before and during weeks 2, 4, 8, 12, 16, 20, 24, 28, and 30 of therapy and again up to 172 weeks after cessation of treatment. In all patients there was an impressive improvement in clinical symptoms, especially a decrease in seborrhea and inflammatory lesions. Simultaneously, the gram-negative bacteria disappeared from the facial skin. Full clinical bacteriological remission was achieved in 9 patients within a period of up to 43 months, with minor recurrences of the disease in the remaining 4 patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943234     DOI: 10.1007/bf00407743

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  20 in total

1.  Gram-negative folliculitis in acne vulgaris.

Authors:  J E Fulton; K McGinley; J Leyden; R Marples
Journal:  Arch Dermatol       Date:  1968-10

2.  Gram-negative folliculitis--a complication of antibiotic therapy in acne vulgaris.

Authors:  J J Leyden; R R Marples; O H Mills; A M Kligman
Journal:  Br J Dermatol       Date:  1973-06       Impact factor: 9.302

3.  A new method for the quantitative investigation of cutaneous bacteria.

Authors:  P Williamson; A M Kligman
Journal:  J Invest Dermatol       Date:  1965-12       Impact factor: 8.551

4.  A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population.

Authors:  K King; D H Jones; D C Daltrey; W J Cunliffe
Journal:  Br J Dermatol       Date:  1982-11       Impact factor: 9.302

5.  [In-vivo testing of antiinflammatory effects caused by 13-cis-retinoic acid (author's transl)].

Authors:  J Nikolowski; G Plewig; C Hofmann
Journal:  Dermatol Monatsschr       Date:  1982-03

6.  Treatment of Gram-negative folliculitis with 13-cis-retinoic acid.

Authors:  D H Jones; W J Cunliffe; K King
Journal:  Br J Dermatol       Date:  1982-08       Impact factor: 9.302

7.  [13-cis retinoic acid in the oral therapy of acne conglobata. Results of a multi-center study].

Authors:  G Plewig; H Gollnick; W Meigel; H Wokalek
Journal:  Hautarzt       Date:  1981-12       Impact factor: 0.751

8.  Gram-negative folliculitis - recognition and treatment.

Authors:  W D James; J J Leyden
Journal:  J Am Acad Dermatol       Date:  1983-07       Impact factor: 11.527

9.  Effect of 13-cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne.

Authors:  J J Leyden; K J McGinley
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

10.  [Oral treatment of rosacea with 13-cis-retinoic acid].

Authors:  J Nikolowski; G Plewig
Journal:  Hautarzt       Date:  1981-11       Impact factor: 0.751

View more
  2 in total

1.  Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne.

Authors:  K R Lumsden; A M Nelson; M C Dispenza; K L Gilliland; Z Cong; A L Zaenglein; D M Thiboutot
Journal:  Br J Dermatol       Date:  2011-08       Impact factor: 9.302

Review 2.  Isotretinoin; A review on the Utilization Pattern in Pregnancy.

Authors:  Sajad Khiali; Afshin Gharekhani; Taher Entezari-Maleki
Journal:  Adv Pharm Bull       Date:  2018-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.